Letrozole-Assisted Ovulation Induction Combined with Lifestyle Modification in Women with PCOS: A Review
DOI:
https://doi.org/10.12775/QS.2026.87.67448Keywords
letrozole, off-label use, ovulation induction, female infertility, polycystic ovary syndrome, aromatase inhibitors, diet, lifestyle modification, stimulated cyclearAbstract
Introduction. Polycystic ovary syndrome (PCOS) is a leading cause of anovulatory infertility. Lifestyle modification remains the foundation of treatment, yet many women require pharmacological ovulation induction. Letrozole, an aromatase inhibitor originally developed for breast cancer therapy, has emerged as a promising first-line agent for women with PCOS.
Aim. The aim of this article is to assess whether it is clinically appropriate to use letrozole in addition to physical activity and nutrition to achieve better ovulation outcomes in women with PCOS trying to improve infertility.
Review methods. A thorough examination of research articles on PubMed and Google Scholar was conducted using search phrases that included the following keywords: letrozole/ off-label use/ ovulation induction/ female infertility/ polycystic ovary syndrome/ aromatase inhibitors/ diet/ lifestyle modification/ stimulated cyclear.
References
1. Shukla, A., Rasquin, L. I., & Anastasopoulou, C. (2025). Polycystic Ovarian Syndrome.NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK459251/
2. Saadati, S., Mason, T., Godini, R., Vanky, E., Teede, H., & Mousa, A. (2025). Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges. https://doi.org/10.1111/dom.16422
3. World Health Organization. (2025). Polycystic ovary syndrome – fact sheet. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
4. Kaltsas, A., Efthimiou, A., Roidos, C., Tzikoulis, V., Georgiou, I., Sotiriadis, A., Zachariou, A., Chrisofos, M., Sofikitis, N., & Dimitriadis, F. (2025). Letrozole at the Crossroads of Efficacy and Fetal Safety in Ovulation Induction: A Narrative Review. Biomedicines, 13(9). https://doi.org/10.3390/biomedicines13092051
5. Bednarska, S., & Siejka, A. (2017). The pathogenesis and treatment of polycystic ovary syndrome: What's new? https://doi.org/10.17219/acem/59380
6. Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016). The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. https://doi.org/10.1093/humrep/dew218
7. Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. https://www.fertstert.org/article/S0015-0282(03)02853-X/fulltext
8. Collée, J., Mawet, M., Tebache, L., Nisolle, M., & Brichant, G. (2021). Polycystic ovarian syndrome and infertility: Overview and insights of the putative treatments. https://doi.org/10.1080/09513590.2021.1958310
9. Legro, R. S., Dodson, W. C., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., … Dokras, A. (2016). Randomized controlled trial of preconception interventions in infertile women with PCOS.9. https://doi.org/10.1210/9. HYPERLINK "https://doi.org/10.1210/jc.2015-2778"9. jc.2015-2778
10. National Institute of Child Health and Human Development. Treatments for infertility resulting from PCOS.
https://www.nichd.nih.gov/health/topics/pcos/conditioninfo/treatments/infertility
11. World Health Organization. (2023). Infertility – fact sheet. https://www.who.int/news-room/fact-sheets/detail/infertility
12. Feng, J., Wu, Q., Liang, Y., Liang, Y., & Bin, Q. (2025). Epidemiological characteristics of infertility, 1990–2021, and 15-year forecasts: an analysis based on the global burden of disease study 2021. Reproductive Health. https://link.springer.com/article/10.1186/s12978-025-01966-7
13. Mascarenhas, M., & Balen, A. H. (2020). Treatment update for anovulation and subfertility in polycystic ovary syndrome.13. https://doi.org/10.1016/13. HYPERLINK "https://doi.org/10.1016/j.coemr.2020.03.003"13. j.coemr.2020.03.003
14. Chudzicka-Strugała, I., Kubiak, A., Banaszewska, B., Wysocka, E., Zwozdziak, B., Siakowska, M., Pawelczyk, L., & Duleba, A. J. (2024). Six-month randomized, placebo-controlled trial of synbiotic supplementation in women with PCOS undergoing lifestyle modifications. https://doi.org/10.1007/s00404-024-07833-3
15. Abdollahzade Delavar, M., Agajani Delavar, M., Ghadimi, R., Esmaeilzadeh, S., & Amiri, M. (2025). Impact of a health coaching intervention on anthropometric indicators, physical activity, and life style of infertile women with polycystic ovary syndrome: A quasi-experimental study https://doi.org/10.1186/s13104-025-07232-0
16. Xie, Y., Li, P., Hao, G., Deng, W., Zhao, J., Gao, S., Deng, B., Li, Y., Deng, M., Yuan, Y., Fan, Q., Zhang, N., Zhao, Z., & Shi, Y. (2025). Letrozole ovulation regimen for frozen-thawed embryo transfer in women with polycystic ovary syndrome: A multi-centre randomised controlled trial. Reproductive Biology and Endocrinology, 23(1). https://doi.org/10.1186/s12958-025-01432-w
17. Karakaya, S., Kumtepe, Y., Al, R. A., Senocak, G., & Yılmaz, E. (2025). A Randomized Trial of Stair-Step Letrozole versus Traditional Letrozole for Subfertile Women with Polycystic Ovary Syndrome. Nigerian Journal of Clinical Practice. https://doi.org/10.4103/njcp.njcp_516_24
18. Mehrabian, F., Zamani Dehkordi, N., Zakerinasab, F., Zarimeidani, F., Rahmati, R., Lotfizadeh, M., Ataei-Goujani, H., Naghshineh, E., & Ghasemi Tehrani, H. (2025). Extended Letrozole Treatment for Ovulation Induction and Clinical Pregnancy in Conventional Treatment-resistant Polycystic Ovary Syndrome Patients: A Prospective Parallel Randomized Clinical Trial. Reproductive Biology and Endocrinology, 23(1). https://doi.org/10.1007/s13224-025-02163-z
19. Mandelbaum, R. S., Agarwal, R., Melville, S., Violette, C. J., Winer, S., Shoupe, D., Matsuo, K., Paulson, R. J., & Quinn, M. M. (2024). A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome.Xenon Fertility & Reproduction (X-FRE). https://doi.org/10.1016/j.xfre.2024.03.004
20. Franik, S., Kremer, J. A. M., Nelen, W. L. D. M., & Farquhar, C. (2014). Aromatase inhibitors for subfertile women with PCOS. https://doi.org/10.1002/14651858.CD010287.pub2
21. Pavone, M. E., & Bulun, S. E. (2013). The use of aromatase inhibitors for ovulation induction and superovulation.21. https21. HYPERLINK "https://doi.org/10.1210/jc.2013-1328"21. ://doi.org/10.1210/21. HYPERLINK "https://doi.org/10.1210/jc.2013-1328"21. jc.2013-1328
22. Polyzos, N. P., Tzioras, S., Badawy, A. M., Valachis, A., Dritsas, C., & Mauri, D. (2009). Aromatase inhibitors for female infertility: a Systematic review of the literature. https://doi.org/10.1016/j.rbmo.2009.06.008
23. Franik, S., Le, Q.-K., Kremer, J. A. M., Kiesel, L., & Farquhar, C. (2018). Aromatase inhibitors (letrozole) for ovulation induction in infertile women with PCOS. https://doi.org/10.1002/14651858.CD010287.pub4
24. Willem M J A Verpoest et al., Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Vol 13. No 2. 2006 166-172 Reproductive BioMedicine Online; https://pubmed.ncbi.nlm.nih.gov/16895628/
25. Bülow, N. S., Wissing, M. L., Macklon, N., Pinborg, A., & Løssl, K. (2024). Reproductive outcomes after letrozole-stimulated vs artificial FET cycles in women with PCOS and/or oligo-anovulation: a systematic review and meta-analysis. https://doi.org/10.1093/humupd/dmaf011
26. Bhatnagar, A. S. (2007). The discovery and mechanism of action of letrozole. https://doi.org/10.1007/s10549-007-9696-3
27. Yang, A.-M., Cui, N., Sun, Y.-F., & Hao, G.-M. (2021). Letrozole for female infertility.27. https://doi.org/10.3389/27. HYPERLINK "https://doi.org/10.3389/fendo.2021.676133"27. fendo.2021.676133
28. Ovulation induction by means of letrozole. https://tidsskriftet.no/2009/02/oversiktsartikkel/ovulasjonsinduksjon-ved-bruk-av-letrozol
29. European Medicines Agency. Femara – referral information.https://www.ema.europa.eu/en/medicines/human/referrals/femara
30. Pundir, J., Achilli, C., Bhide, P., Sabatini, L., Legro, R. S., Rombauts, L., Thangaratinam, S. (2021). Risk of fetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis https://doi.org/10.1093/humupd/dmaa055
31. Requena, A., Herrero, J., Landeras, J., Navarro, E., Neyro, J. L., Salvador, C., Fábregues, F. (2008). Use of letrozole in assisted reproduction: A systematic review and meta-analysis. https://doi.org/10.1093/humupd/dmn033
32. Tatsumi, T., Jwa, S. C., Kuwahara, A., Irahara, M., Kubota, T., & Saito, H. (2017). No increased risk of congenital anomalies following letrozole use in assisted reproductive technology. https://doi.org/10.1093/humrep/dew280
33. Liu, Z., Geng, Y., Huang, Y., Hu, R., Li, F., Song, Y., & Zhang, M. (2024). Letrozole vs clomiphene citrate for PCOS: Systematic review and meta-analysis. https://doi.org/10.1097/AOG.0000000000005070
34. Ray, P. B., Ray, A., & Chakraborti, P. S. (2012). Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome https://doi.org/10.1007/s00404-011-2091-7
35. Mandelbaum, R. S., Agarwal, R., Melville, S., & Violette, C. J. (2024). A comparison of letrozole regimens for ovulation induction https://doi.org/10.1016/j.xfre.2024.03.004
36. Zeng, M. F., Zhou, X., & Duan, J. L. (2021). Stimulated cycle vs artificial cycle for FET in PCOS: Meta-analysis.36. https36. HYPERLINK "https://doi.org/10.1080/09513590.2020.1867976"36. ://doi.org/10.1080/09513590.2020.1867976
37. Tulandi, T., Martin, J., Al-Fadhli, R., Kabli, N., Forman, R., Hitkari, J., Casper, R. F. (2006). Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene.37. https37. HYPERLINK "https://doi.org/10.1016/j.fertnstert.2006.03.014"37. ://doi.org/10.1016/37. HYPERLINK "https://doi.org/10.1016/j.fertnstert.2006.03.014"37. j.fertnstert.2006.03.014
38. Tatsumi, T., Jwa, S. C., Kuwahara, A., Irahara, M., Kubota, T., & Saito, H. (2017). No increased risk of congenital anomalies following letrozole use in assisted reproductive technology. https://doi.org/10.1093/humrep/dew280
39. Wang, B., Lin, H., Xia, R., Lin, S., & Li, Z. (2024). Evaluation of birth outcomes, congenital anomalies and neonatal complications of singletons born to infertile women treated with letrozole: A retrospective cohort study https://doi.org/10.3892/etm.2024.12596
40. Salari, N., Nankali, A., Ghanbari, A., Jafarpour, S., Ghasemi, H., Dokaneheifard, S., & Mohammadi, M. (2024). Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis https://doi.org/10.1007/s00404-024-07607-x
41. Mohammad Sadeghi, H., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022). Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. International Journal of Molecular Sciences, 23(2), 583. https://doi.org/10.3390/ijms23020583
42. Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., & Norman, R. J. (2018). Recommendations from the international evidence-based guideline for PCOS. https://doi.org/10.1093/humrep/dey256
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Magdalena Waśniowska, Magdalena Wiernek, Jagoda Węgrzyn
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 13
Number of citations: 0
